In a similar atherosclerosis study, Heim et al. observed that parenteral treatment of HFD-fed ApoE-/- mice with CLO (1 mg/kg/day, intraperitoneally) decreased serum cholesterol levels numerically, but the effect was not statistically significant [10]. Here, APOE is linked to atherosclerosis.